Malaria Chemoprophylaxis and Self ‐Reported Impact on Ability to Work: Mefloquine Versus Doxycycline

ConclusionsSelf‐reported symptoms were common in those that responded and, while the true background rate of adverse effects (off any medication) is unknown, doxycycline had a significantly increased rate compared with mefloquine and was associated with a greater occupational impact. Therefore, this study supports the view that, for organizations which provide malaria chemoprophylaxis to employees free of charge, mefloquine should be the first‐choice antimalarial drug where the only alternative is doxycycline.
Source: Journal of Travel Medicine - Category: Infectious Diseases Authors: Tags: ORIGINAL ARTICLE Source Type: research